What does ‘a good DTx’ look like?

When it comes to digital therapeutics (DTx), there are many permutations, and what distinguishes a ‘good DTx’ can be difficult to define in a space that is constantly evolving. The viability of DTx as a treatment modality hinges on patient and provider adoption, and the consumer is increasingly demanding more from these solutions. As technology rapidly advances, companies need to consider how to evaluate and improve their DTx offerings to ensure that they continue to meet the evolving needs of patients and healthcare providers. If you are faced with questions and challenges around how to demonstrate the value of your DTx solution - join this meeting to gain real life learnings and insights from other digital health experts. This interactive discussion will cover:

• Ensuring positive user experience. What role does human-centred design play in developing user-friendly DTx solutions, and how can patient feedback be incorporated into the design and development process?
• Demonstrating efficacy and effectiveness. What evidence is necessary to demonstrate that a DTx solution is effective and produces clinically meaningful outcomes?
• Stakeholder perspectives on success. What do different stakeholders consider to be a successful DTx solution? How can these perspectives be reconciled, and what trade-offs may need to be made to create a solution that is acceptable to all stakeholders?